GLP-1s (short for glucagon-like peptide-1 receptor agonists) are a group of medications first approved by the FDA in 2005 to help regulate blood sugar in people with Type 2 diabetes
The Data: The oral version showed promising speed, helping patients lose 12% of their body weight in just 13 weeks
If you miss your usual day, inject as soon as you remember as long as the next scheduled dose is at least 2 days away
While nausea can be uncomfortable, fewer than 10% of people in clinical trials stopped their medication because of gastrointestinal issues
If you experience persistent nausea, vomiting, or inability to tolerate food beyond the expected recovery period, seek medical advice before resuming the medication, as these symptoms may indicate ongoing gastrointestinal issues that could be exacerbated by Ozempic
Weight management is a lifelong journey, and ups and downs are a normal part of it